Derm-Biome and TransBIOtech Awarded $450,000 ARD Grant Funding for Inflammatory Disease and Skin Aging Research
The awarded grant will span a total of 3 years.
The awarded grant will span a total of 3 years.
The country’s only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.
James Song, MD, addressed current challenges in the AD treatment landscape and compared biologics.
This cohort study evaluates the association between antihypertensive drug prescriptions and diagnoses of eczematous dermatitis among older adults in a large nationally representative cohort.
Jason Hawkes, MD, MS, gives an overview of what clinicians need to know today about this rare condition.
Improvements persisted through the 12-week post-treatment follow-up, indicating sustained efficacy even after discontinuation of dupilumab.
Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.
This systematic review examines the quality of the measurement properties of existing patient-reported outcome measures that assess health-related quality of life in patients with psoriasis.
Thank you for your interest in the 25th Annual Las Vegas Dermatology Seminar in Las Vegas! MedscapeLIVE! is pleased to announce the 2024 seminar, with…
Catch up on coverage from the second day of the 2024 Fall Clinical Dermatology Conference for PAs and NPs in Scottsdale, Arizona.
Marc Serota, MD, provided clinical pearls to consider for patients on biologics, particularly dupilumab.